Definitive Healthcare Sees Q4 2023 Adj. EPS $0.06-$0.08 Vs $0.04 Est.; Revenue $65.5M-$66.4M Vs $66.83M Est.
Portfolio Pulse from Benzinga Newsdesk
Definitive Healthcare forecasts Q4 2024 adjusted EPS to be between $0.06-$0.08, higher than the estimated $0.04. However, the company's revenue projection of $65.5M-$66.4M is slightly lower than the estimated $66.83M.
November 02, 2023 | 9:54 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Definitive Healthcare's Q4 2024 adjusted EPS forecast is higher than estimates, which could be positive for the stock. However, the lower revenue projection might offset this positive impact.
Definitive Healthcare's higher than expected EPS forecast for Q4 2024 could be a positive signal for investors, potentially driving the stock price up. However, the lower revenue projection could be a concern, potentially offsetting the positive impact of the EPS forecast. Therefore, the overall impact on the stock is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100